Breaking Tarik Skubal Shines in Dodgers Debut at Wrigley Field Professors Sue Texas A&M System Over Restrictions on Race, Gender, Sexuality Topics Brazil Reduces Diplomatic Presence in Argentina Amid President Milei’s Rhetoric Robby Albarado, Two-Time Preakness-Winning Jockey, Dies at 52 Wildfire Devastates Okanagan Indian Band, Destroying Hundreds of Homes

Tuesday August 4, 2026

Reporter

Eli Lilly and Company

3Articles Published

5Communities Covered

Published Articles

Press Release

Lilly’s olomorasib receives U.S. FDA’s Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer

Aug 3

Press Release

Lilly’s triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C

Jul 23

Press Release

Lilly confirms date and conference call for second-quarter 2026 financial results announcement

Jul 22